Reactivity of SH-Positive and SH-Negative Neutrophils With a Panel of CD16 MoAbs.
MoAb . | SH-Negative . | SH-Positive . | |||
---|---|---|---|---|---|
NA1NA1 (n = 2) . | NA1NA2 (n = 3) . | NA2NA2 (n = 2) . | NA1NA2 (n = 3) . | ||
mfi . | mfi ± SD . | mfi . | mfi ± SD . | Relative to NA(1+,2+)SH(−) . | |
Control | 14 | 15 ± 5 | 12 | 19 ± 7 | — |
Anti-pan FcγRIII | |||||
CLBFcRgran1 | 1,764 | 1,970 ± 609 | 2,409 | 3,345 ± 324 | 170% |
3G8 | 1,427 | 1,309 ± 820 | 1,426 | 1,555 ± 535 | 119% |
BW209/2 | 767 | 989 ± 298 | 956 | 1,611 ± 563 | 163% |
MEM154 | 1,075 | 1,117 ± 568 | 1,198 | 1,636 ± 445 | 140% |
Anti-NA1 FcγRIII | |||||
MG38 | 415 | 311 ± 130 | 16 | 248 ± 95 | 80% |
CLBgran11 | 1,934 | 1,141 ± 317 | 17 | 994 ± 149 | 87% |
Anti-NA2 FcγRIII | |||||
GRM1 | 30 | 914 ± 439 | 1,480 | 1,585 ± 568 | 173% |
PEN1 | 24 | 149 ± 153 | 270 | 834 ± 153 | 560% |
MoAb . | SH-Negative . | SH-Positive . | |||
---|---|---|---|---|---|
NA1NA1 (n = 2) . | NA1NA2 (n = 3) . | NA2NA2 (n = 2) . | NA1NA2 (n = 3) . | ||
mfi . | mfi ± SD . | mfi . | mfi ± SD . | Relative to NA(1+,2+)SH(−) . | |
Control | 14 | 15 ± 5 | 12 | 19 ± 7 | — |
Anti-pan FcγRIII | |||||
CLBFcRgran1 | 1,764 | 1,970 ± 609 | 2,409 | 3,345 ± 324 | 170% |
3G8 | 1,427 | 1,309 ± 820 | 1,426 | 1,555 ± 535 | 119% |
BW209/2 | 767 | 989 ± 298 | 956 | 1,611 ± 563 | 163% |
MEM154 | 1,075 | 1,117 ± 568 | 1,198 | 1,636 ± 445 | 140% |
Anti-NA1 FcγRIII | |||||
MG38 | 415 | 311 ± 130 | 16 | 248 ± 95 | 80% |
CLBgran11 | 1,934 | 1,141 ± 317 | 17 | 994 ± 149 | 87% |
Anti-NA2 FcγRIII | |||||
GRM1 | 30 | 914 ± 439 | 1,480 | 1,585 ± 568 | 173% |
PEN1 | 24 | 149 ± 153 | 270 | 834 ± 153 | 560% |
Results of three separate experiments with neutrophils of different donors are shown.